Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D04DMO
|
||||
Former ID |
DIB005811
|
||||
Drug Name |
FR-194738
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Hypercholesterolemia [ICD10:E78] | Terminated | [1] | ||
Company |
Fujisawa Pharmaceutical Co Ltd
|
||||
Structure |
![]() |
Download2D MOL |
|||
Formula |
C27H38ClNO2S
|
||||
Canonical SMILES |
C(#CC(C)(C)C)/C=C/CN(Cc1cc(OCC(OCc2cscc2)(C)C)ccc1)CC.C<br />l
|
||||
CAS Number |
CAS 204067-52-7
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Squalene monooxygenase | Target Info | Modulator | [2] | |
KEGG Pathway | Steroid biosynthesis | ||||
Sesquiterpenoid and triterpenoid biosynthesis | |||||
Metabolic pathways | |||||
Biosynthesis of secondary metabolites | |||||
Biosynthesis of antibiotics | |||||
PathWhiz Pathway | Steroid Biosynthesis | ||||
Reactome | Cholesterol biosynthesis | ||||
Activation of gene expression by SREBF (SREBP) | |||||
References | |||||
REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800009590) | ||||
REF 2 | Synthesis and biological activity of a novel squalene epoxidase inhibitor, FR194738. Bioorg Med Chem Lett. 2004 Feb 9;14(3):633-7. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.